Carlos Irarrazabal | Renal Physiology | Best Researcher Award

Posted on by ScienceFather

Dr. Carlos Irarrazabal | Renal Physiology | Best Researcher Award

 

Professor and Universidad de los Andes, Chile

Dr. Carlos Ernesto Irarrazabal Muñoz is a distinguished biochemist and researcher whose contributions to the field of biomedical sciences have had a profound impact, particularly in renal physiology and transplant medicine. With a solid educational foundation, extensive research experience, and numerous awards, Dr. Irarrazabal is a compelling candidate for the Research for Best Researcher Award.

Profile
Education

Dr. Irarrazabal began his academic journey with a Bachelor’s degree in Biochemistry from Universidad de Chile in 1991. He then pursued and completed a Ph.D. in Biomedical Sciences from the same institution in 2001. To further hone his expertise, Dr. Irarrazabal engaged in a prestigious post-doctoral program in Renal Physiology at the National Institutes of Health (NIH) in the United States, from 2002 to 2007. This rigorous training provided him with a robust foundation in biomedical research, particularly in the physiology of the renal system.

Professional Experience

Currently, Dr. Irarrazabal serves as the Head of the Molecular Physiology Laboratory at the Centro de Investigación e Innovación Biomédica (CiiB) at Universidad de los Andes in Chile, where he also holds a professorship in the Faculty of Medicine. His research focuses on the molecular mechanisms underlying renal physiology, with significant implications for understanding and treating kidney-related diseases. His leadership in the Molecular Physiology Laboratory is marked by innovative research that bridges basic science and clinical applications.

Scientific Society Memberships and Editorial Roles

Dr. Irarrazabal is an active member of several prestigious scientific societies, including the American Physiological Society, the Latin American Association of Physiological Sciences (ALACF), the Biology Society of Chile, the Chilean Society of Physiological Sciences, and the Chilean Society of Transplantation. His involvement in these societies reflects his commitment to advancing physiological research both in Chile and internationally.

Innovation and Entrepreneurship

In 2012, Dr. Irarrazabal co-founded KinosticsSpA, a startup focused on developing innovative diagnostic tools. He served as the Scientific Director of KinosticsSpA from 2012 to 2015, guiding the company’s research and development efforts. His entrepreneurial endeavors highlight his ability to translate scientific research into practical applications that benefit society.

Awards and Recognition

Dr. Irarrazabal’s research excellence has been recognized through numerous awards. Notably, he received the Best Scientific Research in Coronary Disease Award at the LIII Congreso Chileno de Cardiología y Cirugía Cardiovascular in 2016, as well as several awards for highly cited and impactful papers in the field of transplantation. His work has also been honored with multiple Innovation Awards from Universidad de los Andes for developing novel methods for monitoring and diagnosing hypoxia-related disorders and acute kidney injury. These accolades underscore his innovative contributions to biomedical research.

Conclusion

Dr. Carlos Ernesto Irarrazabal Muñoz is an exceptional researcher whose work in renal physiology and biomedical sciences has advanced our understanding of critical health issues. His extensive educational background, significant research contributions, and numerous awards make him a highly suitable candidate for the Research for Best Researcher Award. Dr. Irarrazabal’s dedication to scientific innovation and his impact on both the academic and clinical fields exemplify the qualities of a leading researcher deserving of this prestigious recognition.

Publications Top Notes

Urinary exosomes as a source of kidney dysfunction biomarker in renal transplantation

Authors: S Alvarez, C Suazo, A Boltansky, M Ursu, D Carvajal, G Innocenti, …

Citations: 161

Year: 2013

Published In: Transplantation Proceedings

ATM, a DNA damage-inducible kinase, contributes to activation by high NaCl of the transcription factor TonEBP/OREBP

Authors: CE Irarrazabal, JC Liu, MB Burg, JD Ferraris

Citations: 141

Year: 2004

Published In: Proceedings of the National Academy of Sciences of the United States of America

Mesenchymal stem cell injection ameliorates chronic renal failure in a rat model

Authors: S Villanueva, E Ewertz, F Carrión, A Tapia, C Vergara, C Céspedes, …

Citations: 105

Year: 2011

Published In: Clinical Science

Phosphatidylinositol 3-kinase mediates activation of ATM by high NaCl and by ionizing radiation: Role in osmoprotective transcriptional regulation

Authors: CE Irarrazabal, MB Burg, SG Ward, JD Ferraris

Citations: 89

Year: 2006

Published In: Proceedings of the National Academy of Sciences

Human mesenchymal stem cells derived from adipose tissue reduce functional and tissue damage in a rat model of chronic renal failure

Authors: S Villanueva, JE Carreño, L Salazar, C Vergara, R Strodthoff, F Fajre, …

Citations: 86

Year: 2013

Published In: Clinical Science

Placental aromatase is deficient in placental ischemia and preeclampsia

Authors: A Perez-Sepulveda, LJ Monteiro, A Dobierzewska, PP España-Perrot, …

Citations: 82

Year: 2015

Published In: PLoS ONE

Joint effect among p53, CYP1A1, GSTM1 polymorphism combinations and smoking on prostate cancer risk: an exploratory genotype‐environment interaction study

Authors: LA Quiñones, CE Irarrázabal, CR Rojas, CE Orellana, C Acevedo, …

Citations: 69

Year: 2006

Published In: Asian Journal of Andrology

Toll-like receptor 3 pre-conditioning increases the therapeutic efficacy of umbilical cord mesenchymal stromal cells in a dextran sulfate sodium–induced colitis model

Authors: P Fuenzalida, M Kurte, C Fernandez-O’Ryan, C Ibañez, …

Citations: 61

Year: 2016

Published In: Cytotherapy

Chilean pilot study on the risk of lung cancer associated with codon 72 polymorphism in the gene of protein p53

Authors: CE Irarrázabal, C Rojas, R Aracena, C Márquez, L Gil

Citations: 60

Year: 2003

Published In: Toxicology Letters

Proteomic identification of proteins associated with the osmoregulatory transcription factor TonEBP/OREBP: functional effects of Hsp90 and PARP-1

Authors: Y Chen, MP Schnetz, CE Irarrazabal, RF Shen, CK Williams, MB Burg, …

Citations: 57

Year: 2007

Published In: American Journal of Physiology-Renal Physiology

 

Jennifer Vittorio | Health Care | Best Researcher Award

Posted on by ScienceFather

Dr. Jennifer Vittorio | Health Care | Best Researcher Award

Medical Director Pediatric Liver Transplant and NYU Langone Health, United States

Dr. Jennifer Mary Vittorio is a highly accomplished and distinguished physician with extensive expertise in pediatric gastroenterology, hepatology, and transplant hepatology. Her career is marked by significant contributions to the medical field, particularly in the transition of pediatric patients to adult healthcare services. Dr. Vittorio’s extensive education, research, and leadership positions make her a strong candidate for the Research for Best Researcher Award.

Profile
Education

Dr. Vittorio’s educational journey is both impressive and comprehensive. She earned a Bachelor of Science Degree in Neuroscience, graduating Magna Cum Laude from Fairfield University in 2001, with additional minors in Mathematics and Psychology. She continued her medical education at Georgetown University School of Medicine, where she obtained her Doctorate of Medicine in 2006, graduating Cum Laude. Her postdoctoral training includes an internal medicine and pediatrics internship and residency at Georgetown University Hospital, followed by fellowships in Pediatric Gastroenterology, Hepatology, and Nutrition, as well as Pediatric Advanced Transplant Hepatology at Columbia University Medical Center.

Professional Experience

Dr. Vittorio has held numerous prestigious positions throughout her career. Currently, she serves as an Associate Professor of Pediatrics at NYU Grossman School of Medicine and as the Medical Director of the Pediatric Liver Disease and Transplant Program at NYU Langone Transplant Institute. Her previous roles include various faculty and hospital appointments at Columbia University Irving Medical Center, NewYork-Presbyterian Morgan Stanley Children’s Hospital, and the Children’s Hospital at Montefiore. Dr. Vittorio has also initiated and directed several programs focused on pediatric liver transplant patients, highlighting her leadership in both clinical and research settings.

Research Interests

Dr. Vittorio’s research is particularly notable in the field of pediatric transplant hepatology. She is the founder of the PLATINUM (Pediatric Liver to Adult Transition) Program, which focuses on improving the transition readiness of pediatric liver transplant recipients. Her work in this area has led to several influential publications and a leadership role in the American Society of Transplantation’s transition working group. Dr. Vittorio has also served as a site primary investigator for global studies on cholestatic liver diseases, further demonstrating her commitment to advancing medical knowledge and patient care.

Awards and Recognition

Dr. Vittorio’s dedication to her field has earned her numerous awards and honors. These include the Fellow of the Year Award at Columbia University Medical Center, multiple recognitions as a Top Doctor by the New York Times Magazine, and the Fairy Godmother Foundation of New York’s Dream Maker Award. Her recent induction as a Fellow of the American Association for the Study of Liver Diseases (FAASLD) further underscores her exceptional contributions to hepatology.

Conclusion

Dr. Jennifer Mary Vittorio’s extensive qualifications, research accomplishments, and leadership roles make her an outstanding candidate for the Research for Best Researcher Award. Her work has not only advanced the field of pediatric hepatology but has also had a profound impact on the lives of countless patients. Dr. Vittorio’s dedication to her profession and her commitment to improving patient care through research and education exemplify the qualities of a top researcher and leader in the medical field.

Publications Top Notes

  1. Title: “The Crucial Role of Empowerment in Engaging Adolescents and Young Adults for Independence: Essential Strategies and Skills for a Successful Transition”
  • Authors: Vittorio, J., Kosmach-Park, B., King, L.
  • Journal: Pediatric Transplantation
  • Year: 2024
  • Volume/Issue: 28(5)
  • DOI: e14826

      2. Title: “Adult provider role in transition of care for young adult pediatric recipients of liver transplant: An expert position statement”

  • Authors: Vittorio, J., Kosmach-Park, B., Wadhwani, S., Yeh, H., King, L.Y.
  • Journal: Hepatology Communications
  • Year: 2024
  • Volume/Issue: 8(8)
  • DOI: e0486

     3. Title: “Caregivers’ and providers’ perspectives of social and medical care after pediatric liver transplant: Results from the multicenter SOCIAL-Tx study”

  • Authors: Wadhwani, S.I., Alvarado, A., Shifman, H.P., Ackerman, S.L., Lai, J.C.
  • Journal: Liver Transplantation
  • Year: 2024
  • Volume/Issue: 30(7)
  • Pages: 717–727

    4. Title: “The use of once-daily LCP-Tacrolimus with adolescent and young adult solid organ transplant recipients”

  • Authors: Householder, S., Ramakrishnan, A., Chen, J.K., Rundle, A., Vittorio, J.M.
  • Journal: Pediatric Transplantation
  • Year: 2024
  • Volume/Issue: 28(4)
  • DOI: e14777

   5. Title: “Neonatal cholestasis: Timely triumph”

  • Authors: Sharma, S., Thomas, K., Bertino, F., Vittorio, J.
  • Journal: Clinical Liver Disease
  • Year: 2024
  • Volume/Issue: 23(1)
  • DOI: e0135
  • Citations: 0

  6. Title: “Caregiver Perceptions of Social Risk Screening in Pediatric Liver Transplantation: From the Multicenter SOCIAL-Tx Study”

  • Authors: Wadhwani, S.I., Kruse, G., Squires, J., Gottlieb, L.M., Lai, J.C.
  • Journal: Transplantation
  • Year: 2024
  • Volume/Issue: 108(4)
  • Pages: 940–946
  • Citations: 1

  7. Title: “The impact of health literacy on adolescent and young adult pediatric liver transplant recipients”

  • Authors: Baranwal, P., Sathe, M., Lobritto, S.J., Vittorio, J.
  • Journal: Liver Transplantation
  • Year: 2024
  • Volume/Issue: 30(4)
  • Pages: 386–394
  • Citations: 2

  8. Title: “The diagnostic yield of exome sequencing in liver diseases from a curated gene panel”

  • Authors: Kong, X.-F., Bogyo, K., Kapoor, S., Goldstein, D.B., Wattacheril, J.
  • Journal: Scientific Reports
  • Year: 2023
  • Volume/Issue: 13(1)
  • DOI: 21540
  • Citations: 1

 9. Title: “Treatment of Cholestasis in Infants and Young Children”

  • Authors: Heinz, N., Vittorio, J.
  • Journal: Current Gastroenterology Reports
  • Year: 2023
  • Volume/Issue: 25(11)
  • Pages: 344–354
  • Citations: 2

 10. Title: “Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis”

  • Authors: Thompson, R.J., Artan, R., Baumann, U., Horn, P., Kjems, L.
  • Journal: JHEP Reports
  • Year: 2023
  • Volume/Issue: 5(8)
  • DOI: 100782
  • Citations: 8